Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow''s milk protein allergy. En savoir plus sur Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow''s milk protein allergy.
Risk Factors for Incarceration in Patients with Primary Abdominal Wall and Incisional Hernias: A Prospective Study in 4472 Patients. En savoir plus sur Risk Factors for Incarceration in Patients with Primary Abdominal Wall and Incisional Hernias: A Prospective Study in 4472 Patients.
WITHDRAWN: Percutaneous arteriovenous fistulae: Technique feasibility and results. En savoir plus sur WITHDRAWN: Percutaneous arteriovenous fistulae: Technique feasibility and results.
[Alcoholic disease in women what specificities?] En savoir plus sur [Alcoholic disease in women what specificities?]
Sacral nerve modulation for faecal incontinence: influence of age on outcomes and complications. A multicentre study. En savoir plus sur Sacral nerve modulation for faecal incontinence: influence of age on outcomes and complications. A multicentre study.
Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions. En savoir plus sur Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions.
Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis. En savoir plus sur Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis.
[Orthognathic surgery of mandibular asymmetry: which results can we expect with and without chin wing? A cohort out of 51 cases]. En savoir plus sur [Orthognathic surgery of mandibular asymmetry: which results can we expect with and without chin wing? A cohort out of 51 cases].
Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study. En savoir plus sur Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study.